Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters
- PMID: 35429022
- PMCID: PMC9111426
- DOI: 10.1111/apt.16872
Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters
Abstract
This article is linked to Kokkotis et al papers. To view these articles, visit
Conflict of interest statement
The authors have declared no conflicts of interest.
Comment in
-
Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply.Aliment Pharmacol Ther. 2022 May;55(9):1235-1236. doi: 10.1111/apt.16904. Aliment Pharmacol Ther. 2022. PMID: 35429035 Free PMC article.
Comment on
-
Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.Aliment Pharmacol Ther. 2022 Jan;55(2):154-167. doi: 10.1111/apt.16717. Epub 2021 Dec 8. Aliment Pharmacol Ther. 2022. PMID: 34881430
References
-
- Kokkotis G, Kitsou K, Xynogalas I, Spoulou V, Magiorkinis G, Trontzas I, et al. Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments. Aliment Pharmacol Ther. 2022;55(2):154–67. - PubMed
-
- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical